Global Retirement Partners’s SkinHealth Systems SKIN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$34.6K Buy
24,900
+5,000
+25% +$7.23K ﹤0.01% 2578
2025
Q3
$39.6K Sell
19,900
-40,500
-67% -$82.2K ﹤0.01% 2029
2025
Q2
$115K Buy
+60,400
New +$85.1K ﹤0.01% 1366
2024
Q4
$102K Sell
64,400
-5,500
-8% -$8.64K ﹤0.01% 1255
2024
Q3
$101K Buy
69,900
+21,000
+43% +$34.4K ﹤0.01% 1235
2024
Q2
$93.9K Sell
48,900
-8,100
-14% -$22.8K ﹤0.01% 1232
2024
Q1
$253K Sell
57,000
-62,023
-52% -$201K 0.01% 711
2023
Q4
$295K Buy
119,023
+93,123
+360% +$349K 0.01% 618
2023
Q3
$146K Buy
+25,900
New +$182K 0.01% 789
2022
Q2
Sell
-500
Closed -$6K 2864
2022
Q1
$6K Buy
+500
New +$8.25K ﹤0.01% 1845
2021
Q2
Sell
-400
Closed -$4K 1929
2021
Q1
$4K Buy
+400
New +$4.4K ﹤0.01% 1546

Other funds holding SKIN

Global Retirement Partners's SKIN Position: Q4 2025 in Review

Global Retirement Partners increased its SkinHealth Systems (SKIN) stake by 25% in Q4 2025, buying an estimated $7.23K and bringing the position to 24,900 shares worth $34.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2578.

Global Retirement Partners first reported a position in SKIN in Q1 2021 and has held it in 11 quarters since. The position peaked at $295K in Q4 2023. 114 funds tracked by Wall St. Rank hold SKIN as of Q4 2025.

  • Global Retirement Partners held 24,900 shares of SkinHealth Systems worth $34.6K as of Q4 2025.
  • Global Retirement Partners bought 5,000 SkinHealth Systems shares in Q4 2025, an estimated $7.23K.
  • SkinHealth Systems made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #2578 holding.
  • Global Retirement Partners first reported a position in SkinHealth Systems in Q1 2021 and has held it in 11 quarters since.
  • Global Retirement Partners's SkinHealth Systems position peaked at $295K in Q4 2023.
  • 114 funds tracked by Wall St. Rank held SkinHealth Systems as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.